Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds
Open accessAbstract
In this study, we investigated the effect of fiber and pore size of an electrospun scaffold on the polarization of mouse bone marrow-derived macrophages (BMMΦs) towards regenerative (M2) or inflammatory (M1) phenotypes. BMMΦs were seeded on Polydioxanone (PDO) scaffolds electrospun from varying polymer concentrations (60, 100, and 140 mg/ml). Higher polymer concentrations yielded larger diameter fibers with larger pore sizes and porosity. BMMΦ cultured on these scaffolds showed a correlation between increasing fiber/pore size and increased expression of the M2 marker Arginase 1 (Arg1), along with decreased expression of the M1 marker inducible nitric oxide synthase (iNOS). Secretion of the angiogenic cytokines VEGF, TGF-β1 and bFGF was higher among cultures employing larger fiber/pore size scaffolds (140 mg/ml). Using a 3D in vitro angiogenesis bead assay, we have demonstrated that the M2-like profile of BMMΦ induced by the 140 mg/ml is functional. Furthermore, our results show that the pore size of a scaffold is a more critical regulator of the BMMΦ polarization compared to the fiber diameter. The study also shows a potential role for MyD88 in regulating M1 BMMΦ signaling on the large vs. small fiber/pore size PDO scaffold. These data are instructive for the rationale design of implantable prosthetics designed to promote in situ regeneration.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
- Findingown data
BMMΦ (M0s and M2s) infiltration into the fibrous structures was greater in larger fiber/pore size scaffolds.
“The histological evaluation (H&E staining) of PDO scaffolds showed greater BMMΦ (M0s and M2s) infiltration into the fibrous structures of larger fiber/pore size scaffold (Figure 4A).”
Quote in the paperSubstantial claim - Findingown data
Larger fiber/pore sizes induce statistically higher Arg1 expression.
“The larger fiber/pore sizes are able to induce statistically higher Arg1 expression.”
Quote in the paperSubstantial claim - Findingown data
BMMΦ infiltration was statistically higher in the large fiber/pore size scaffold (140 mg/ml) than in the 60 mg/ml scaffold for M0s and M2s.
“The BMMΦ infiltration was statistically higher in the large fiber/pore size scaffold (140 mg/ml) when compared to the 60 mg/ml scaffold.”
Quote in the paperSubstantial claim - Findingown data
Secretion of VEGF, TGF-β1, and bFGF was higher in cultures with larger fiber/pore size scaffolds (140 mg/ml).
“Secretion of the angiogenic cytokines VEGF, TGF-β1 and bFGF was higher among cultures employing larger fiber/pore size scaffolds (140 mg/ml).”
Quote in the paperSubstantial claim - Findingown data
M0s and M2s on the small fiber/pore size PDO (60 mg/ml) scaffold were concentrated at the surface.
“The M0s and M2s in the case of small fiber/pore size PDO (60 mg/ml) scaffold were found concentrated at the surface.”
Quote in the paperNot a substantial claim
- Findingown data
Pre-polarized M2 BMMΦs induce statistically higher Arg1 expression on large fiber/pore sizes on Day 1.
“The pre-polarized M2 BMMΦs induce statistically higher Arg1 expression on the large fiber/pore sizes on Day 1.”
Quote in the paperSubstantial claim - Findingown data
Arg1 expression by M2s was maintained on the large fiber/pore size.
“The Arg1 expression level by M2s was maintained on the large fiber/pore size.”
Quote in the paperNot a substantial claim - Findingown data
BMMΦ cultured on PDO scaffolds showed decreased iNOS expression with increasing fiber/pore size.
“along with decreased expression of the M1 marker inducible nitric oxide synthase (iNOS).”
- Also stated in: § 3.4 Arginase and iNOS Expression · plain
“The expression of iNOS decreased with increasing fiber/pore sizes.”
Quote in the paperSubstantial claim - Also stated in: § 3.4 Arginase and iNOS Expression · plain
- Findingcitation
For M1s, greater infiltration was observed on the 60 mg/ml scaffold.
“However, in the case of M1s, greater infiltration was observed on the 60 mg/ml.”
Quote in the paperSubstantial claim - Findingown data
With increasing fiber/pore sizes, BMMΦ infiltration of the scaffold cross-sectional area for M0s and M2s increased linearly.
“As expected, the results showed that with increasing fiber/pore sizes, BMMΦ infiltration of the scaffold cross-sectional area for M0s and M2s increased linearly.”
Quote in the paperSubstantial claim - Findingown data
M2s on the small fiber/pore size PDO increased their Arg1 production on Day 3 compared to Day 1.
“It was also observed that the M2s on the small fiber/pore size PDO increased their Arg1 production on Day 3 compared to Day 1.”
Quote in the paperNot a substantial claim - Findingown data
On Day 3, M0s were unable to maintain Arg1 expression.
“On Day 3, it was observed that M0s were unable to maintain Arg1 expression (Figure 6).”
Quote in the paperSubstantial claim - Findingnone given
MyD88 has a potential role in regulating M1 BMMΦ signaling on large versus small fiber/pore size PDO scaffolds.
“The study also shows a potential role for MyD88 in regulating M1 BMMΦ signaling on the large vs. small fiber/pore size PDO scaffold.”
Quote in the paperNot a substantial claim - Findingown data
iNOS expression was totally abolished by Day 3 on all fiber/pore sizes of PDO.
“The expression of iNOS was totally abolished by Day 3 on all fiber/pore sizes of PDO.”
Quote in the paperNot a substantial claim - Findingown data
On Day 3, larger fiber/pore sizes induced statistically higher Arg1 by M1s.
“Similar to day 1, the larger fiber/pore sizes induced statistically higher Arg1 by M1s on Day 3.”
Quote in the paperSubstantial claim - Findingown data
BMMΦ cultured on PDO scaffolds showed a correlation between increasing fiber/pore size and increased Arg1 expression.
“BMMΦ cultured on these scaffolds showed a correlation between increasing fiber/pore size and increased expression of the M2 marker Arginase 1 (Arg1)”
- Also stated in: § 3.4 Arginase and iNOS Expression · hedged
“The results indicated a correlation between Arg1 expression and increasing fiber/pore sizes in all BMMΦ groups (M0, M1 and M2) on Day 1 (Figures 5A and B).”
Quote in the paperSubstantial claim - Also stated in: § 3.4 Arginase and iNOS Expression · hedged
- Findingown data
On Day 3, M1 and M2 BMMΦs were able to maintain Arg1 expression.
“However, M1 and M2s were able to maintain Arg1 expression.”
Quote in the paperSubstantial claim - Findingown data
For M2 macrophages, sprout length induced by conditioned media from the 140 mg/ml scaffold was statistically higher than from the 60 mg/ml scaffold.
“In the case of M2s, the sprout length induced by the conditioned media from 140 mg/ml scaffold was statistically higher compared to the 60 mg/ml scaffold.”
Quote in the paperSubstantial claim - Findingown data
Significantly higher density of sprouts was induced by M0, M1 and M2 macrophages cultured on the larger fiber/pore sizes.
“It was observed that significantly higher density of sprouts was induced by BMMΦs (M0s, M1s and M2s) cultured on the larger fiber/pore sizes.”
Quote in the paperSubstantial claim - Findingown data
Sprout lengths induced by M1 macrophages did not differ across fiber/pore sizes.
“The sprout lengths induced by M1s were not different across different fiber/pore sizes.”
Quote in the paperNot a substantial claim - Findingown data
MyD88 knockout and wild-type M0 and M2 macrophages expressed similar levels of Arg1 on both the 60 mg/ml and 140 mg/ml PDO scaffolds.
“The MyD88 knockout and wild-type (WT) M0s and M2s expressed similar levels of Arg1 on both 60 mg/ml and 140 mg/ml PDO scaffolds.”
Quote in the paperSubstantial claim - Findingown data
No sprouting was observed from conditioned media of M0 macrophages cultured on the 60 mg/ml scaffold.
“No sprouting was observed from the conditioned media of M0s cultured on the 60 mg/ml scaffold.”
Quote in the paperSubstantial claim - Findingown data
Average sprout length induced by M0 macrophages on the 140 mg/ml scaffold was statistically higher than on the 100 mg/ml and 60 mg/ml scaffolds.
“The average sprout length induced by M0s on the larger fiber/pore size (140 mg/ml) was statistically higher when compared to smaller fiber/pore sizes (100 mg/ml and 60 mg/ml PDO scaffolds).”
Quote in the paperSubstantial claim - Findingown data
Arg1 expression by M2 macrophages was reduced on the compressed 140 mg/ml scaffold compared with the normal 140 mg/ml scaffold.
“The Arg1 expression by M2s was reduced on the compressed 140 mg/ml scaffold compared to the normal 140 mg/ml scaffold (Figure 13).”
Quote in the paperSubstantial claim - Findingown data
For M0 macrophages, VEGF production was significantly higher on the larger fiber/pore size PDO.
“In the case of M0s, the production of VEGF was significantly higher on the larger fiber/pore size PDO.”
Quote in the paperSubstantial claim - Findingown data
IL-6 was produced in the highest quantities by M1 phenotype macrophages.
“IL-6 was also produced in highest quantities by M1 phenotype BMMΦs.”
Quote in the paperNot a substantial claim - Findingown data
bFGF was produced in comparable amounts by macrophages of all three phenotypes (M0, M1 and M2).
“bFGF was also produced in comparable amounts by BMMΦ of all three phenotypes; M0s, M1s and M2s.”
Quote in the paperNot a substantial claim - Findingown data
MIP-1α production was statistically higher on the 140 mg/ml scaffold than the 60 mg/ml scaffold for M0, M1 and M2 macrophages.
“The production of MIP-1α was statistically higher on the larger fiber/pore size scaffold (140 mg/ml) compared to the 60 mg/ml scaffold in the case of M0s, M1s and M2s.”
Quote in the paperSubstantial claim - Findingown data
For M1 and M2 macrophages, VEGF showed no differences with respect to fiber/pore size.
“In the case of M1s and M2s, no differences with respect to fiber/pore sizes were noted.”
Quote in the paperNot a substantial claim - Findingown data
Compared with the solid mandrel, the air-flow mandrel produced higher Arg1 expression in M2 macrophages.
“Compared to the solid mandrel, the air flow mandrel showed higher expression of Arg1 on M2s.”
Quote in the paperSubstantial claim - Findingown data
The only difference between MyD88 knockout and wild-type cells was in M1 macrophages cultured on the 140 mg/ml scaffold.
“The only difference was observed in the case of M1s cultured on the 140 mg/ml scaffold (Figure 9).”
Quote in the paperSubstantial claim - Findingown data
For M0 macrophages, VEGF level on the 140 mg/ml scaffold increased on Day 3 relative to Day 1.
“the level of VEGF on the 140 mg/ml scaffold increased on Day 3 compared to Day 1”
Quote in the paperNot a substantial claim - Findingown data
In all three phenotypes (M0, M1 and M2), conditioned media from macrophages cultured on the larger fiber/pore size PDO produced greater sprouting.
“In all cases (M0s, M1s and M2s), the images showed greater sprouting from the conditioned media from BMMΦ cultured on the larger fiber/pore size PDO”
Quote in the paperSubstantial claim - Findingown data
Sprout length for M0 macrophages on the 140 mg/ml scaffold was statistically higher than all other samples tested except M2 macrophages on the 140 mg/ml scaffold.
“The sprout length in the case of M0s cultured on the 140 mg/ml scaffold was statistically higher than all other samples tested except for the M2s cultured on the 140 mg/ml scaffold.”
Quote in the paperSubstantial claim - Findingown data
TGF-β1 levels increased with increasing fiber/pore sizes in M0, M1 and M2 macrophages.
“The levels of TGF-β1 increased with increasing fiber/pore sizes in M0s, M1s and M2s.”
Quote in the paperSubstantial claim - Findingown data
No differences were observed between MyD88 knockout and wild-type M1 macrophages cultured on the 60 mg/ml scaffold.
“No differences were observed in MyD88 knockout and WT M1s cultured on the 60 mg/ml scaffold.”
Quote in the paperSubstantial claim - Findingown data
TGF-β1 expression was maintained until Day 3.
“The TGF-β1 expression was maintained until Day 3.”
Quote in the paperNot a substantial claim - Findingown data
TNF-α secretion was highest from M1-polarized bone-marrow-derived macrophages, roughly 300-fold above M0 and M2 cells.
“The highest levels of TNF-α were produced from the M1 phenotype BMMΦ (~ 300 times greater compared to M0s and M2s).”
Quote in the paperNot a substantial claim - Findingown data
TNF-α levels did not differ significantly between PDO scaffolds of different fiber/pore sizes.
“The levels of TNF-α were not found to be significantly different between PDO scaffolds of different fiber/pore sizes.”
Quote in the paperNot a substantial claim - Findingown data
MCP-1 levels were statistically higher on the 140 mg/ml PDO scaffold than the 60 mg/ml scaffold for M1 macrophages on Day 1.
“The levels of MCP-1 were statistically higher on the 140 mg/ml PDO scaffold compared to the 60 mg/ml scaffold in the case of M1s on Day 1.”
Quote in the paperNot a substantial claim - Findingown data
MyD88 knockout M1 macrophages showed severely impaired Arg1 expression on the 140 mg/ml scaffold compared with wild-type M1 macrophages.
“The MyD88 knockout M1s showed severely impaired ability to express Arg1 on the 140 mg/ml scaffold when compared to the WT M1s.”
Quote in the paperSubstantial claim - Findingown data
MIP-1α levels were much higher in M0 macrophages than in M1 and M2 macrophages.
“The levels of MIP-1α were much higher in M0s compared to M1s and M2s.”
Quote in the paperNot a substantial claim - Findingown data
For M0 macrophages, VEGF level on the 60 mg/ml scaffold was much lower on Day 3 than on Day 1.
“compared to Day 1, the level of VEGF on the 60 mg/ml scaffold were much lower on Day 3”
Quote in the paperSubstantial claim - Findingown data
Comparable levels of TGF-β1 were produced by all three macrophage phenotypes (M0, M1 and M2).
“Comparable levels of TGF-β1 were produced by all three BMMΦ phenotypes; M0s, M1s and M2s.”
Quote in the paperNot a substantial claim - Study design and conductown data
Macrophage differentiation was verified by flow cytometry, showing >96% CD68+ cells.
“Macrophage differentiation was verified by flow cytometry, showing >96% CD68+ (data not shown).”
Quote in the paperSubstantial claim - Premisecitation
PDO was chosen because electrospinning at a particular concentration produces scaffolds with a fairly uniform distribution of fiber sizes and pore sizes.
“PDO was chosen for this study because when electrospun at a particular concentration, it produces scaffolds with a fairly uniform distribution of fiber sizes and pore sizes [18, 20].”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
The M2-like profile of BMMΦ induced by the 140 mg/ml scaffold is functional, as demonstrated by a 3D in vitro angiogenesis bead assay.
“Using a 3D in vitro angiogenesis bead assay, we have demonstrated that the M2-like profile of BMMΦ induced by the 140 mg/ml is functional.”
Quote in the paperSubstantial claim - Interpretationown data
Larger fiber/pore sizes (140 mg/ml PDO scaffold, 14 μm pore size) polarize naïve BMMΦ (M0s) towards an M2 phenotype.
“These results indicate that the larger fiber/pore sizes (140 mg/ml PDO scaffold, 14 µm pore size) polarize towards an M2 phenotype in naïve BMMΦ (M0s).”
Quote in the paperSubstantial claim - Interpretationown data
Pore size of a scaffold is a more critical regulator of BMMΦ polarization than fiber diameter.
“Furthermore, our results show that the pore size of a scaffold is a more critical regulator of the BMMΦ polarization compared to the fiber diameter.”
Quote in the paperSubstantial claim - Premisecitation
MΦ cell lines are not functionally equivalent to primary MΦs.
“While MΦ cell lines are useful and easy to manipulate, they are not functionally equivalent to primary MΦs [25].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] Chamberlain, 2009, Phenotypic non-equivalence of murine (monocyte-) macrophage cells in biomaterial and inflammatory models, J Biomed Mater Res A source
Not checked in the free run.
- Interpretationown data
Scaffolds with large and small fiber/pore sizes signal to M1 macrophages differently.
“This indicates that scaffolds with large and small fiber/pore sizes signal to M1s differently.”
Quote in the paperSubstantial claim - Premisereasoning
The separate contributions of fiber size and pore size to macrophage response had not been analysed previously.
“Therefore, the analysis of separate contributions of fiber and pore size to MΦ response has not been done previously.”
Quote in the paperSubstantial claim - Interpretationown data
Naïve macrophages acquire a functional M2-like phenotype when in contact with the bigger fiber/pore size scaffold.
“this study shows that naïve BMMΦs acquire a functional M2-like phenotype when in contact with the bigger fiber/pore size scaffold.”
- Also stated in: § 5. Conclusion · plain
“the naïve BMMΦs acquire a functional M2-like phenotype when in contact with the bigger fiber/pore size scaffold.”
Quote in the paperSubstantial claim- Rests on an assumption: An M2 macrophage phenotype promotes healing and integration of the biomaterial with the host tissue, enhancing tissue regeneration.
- Also stated in: § 5. Conclusion · plain
- Interpretationown data
A naïve M0 macrophage cultured on the 140 mg/ml scaffold has angiogenic capacity similar to a pre-polarized M2 macrophage.
“This result shows that a naïve BMMΦ (M0) cultured on the 140 mg/ml scaffold possesses angiogenic capacity similar to a pre-polarized M2.”
- Also stated in: § 4. Discussion · boosted
“we have shown that a naïve BMMΦ (M0) when cultured on the 140 mg/ml scaffold not only acquires a more M2-like phenotype but is also as angiogenic as a pre-polarized M2.”
Quote in the paperSubstantial claim - Also stated in: § 4. Discussion · boosted
- Interpretationown data
Varying the fiber and pore dimensions of an electrospun scaffold can modulate the macrophage phenotype.
“In this study we have demonstrated that by varying the fiber and pore dimensions of an electrospun scaffold, the BMMΦ phenotype can be modulated.”
Quote in the paperSubstantial claim - Premisecitation
Recognizing the predominant macrophage phenotypic profile can provide a tool to predict and possibly promote a tissue regenerative outcome.
“Recognition of the predominant MΦ phenotypic profile can provide a tool by which a tissue regenerative outcome can be predicted and possibly promoted [4].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Brown, 2009, Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component, Biomaterials source
Not checked in the free run.
- Interpretationreasoning
The greater sprouting than VEGF alone can be attributed to macrophage conditioned media containing many growth factors besides VEGF, such as TGF-β1 and bFGF, that also play roles in angiogenesis.
“This can be attributed to the fact that BMMΦ conditioned media contains many growth factors besides VEGF (such as TGF-β1 and bFGF) which also play crucial roles in the process of angiogenesis.”
Quote in the paperSubstantial claim - Interpretationown data
The larger fiber/pore size PDO scaffold has greater potential for macrophage-mediated angiogenesis than the 60 mg/ml scaffold.
“Therefore, these studies show that the larger fiber/pore size PDO scaffold has greater potential for BMMΦ mediated angiogenesis compared to the 60 mg/ml scaffold.”
Quote in the paperSubstantial claim - Interpretationown data
Pore size is a more crucial regulator of Arg1 expression and of macrophage phenotype modulation towards an M2 phenotype than fiber size.
“These results show that pore size is a more crucial regulator of the M2 phenotype compared to the fiber size.”
- Also stated in: § 4. Discussion · plain
“compared to the fiber size, pore size is a more crucial regulator of Arg1 expression and BMMΦ phenotype modulation towards an M2 phenotype.”
- Also stated in: § 5. Conclusion · plain
“compared to the fiber size, pore size of a scaffold is a more critical regulator of the BMMΦ phenotype modulation towards an M2 phenotype.”
Quote in the paperSubstantial claim - Also stated in: § 4. Discussion · plain
- May combine two claims. 22
- Classified as probably not a substantial claim. 12
May combine two claims.
Findingown dataCompressing 140 mg/ml PDO scaffolds reduced pore size from 14 μm to 9 μm without impacting fiber size.
“This led to a decrease in the pore size of the scaffold from 14 µm to 9 µm without impacting the fiber size.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataStatistical differences in scaffold properties were observed only between 60 mg/ml and 140 mg/ml scaffolds; 100 mg/ml and 140 mg/ml scaffolds were not statistically different.
“The statistical differences were only observed in the case of 60 mg/ml and 140 mg/ml scaffolds. The properties of 100 mg/ml and 140 mg/ml scaffolds were not statistically different from one another.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn M1 pre-polarized BMMΦ, iNOS expression is downregulated by increasing fiber/pore size, with statistical difference only between 100 mg/ml and 140 mg/ml PDO scaffolds.
“The expression of iNOS in M1 pre-polarized BMMΦ is downregulated by increasing fiber/pore size (Figures 5A and C). However, it should be noted that the statistical difference was only found between 100 mg/ml and 140 mg/ml PDO scaffold.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationThe 60 mg/ml PDO scaffold was made more porous using air-flow impedance electrospinning without significantly changing its fiber size.
“In order to investigate which property of the PDO scaffolds plays an important role in BMMΦ phenotype modulation, the 60 mg/ml PDO scaffolds were made more porous and the 140 mg/ml PDO scaffolds were made less porous without significantly changing their fiber size.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIncreasing the PDO polymer concentration during electrospinning linearly increased fiber size, pore size, and porosity, while decreasing the surface area to volume ratio.
“Higher polymer concentrations yielded larger diameter fibers with larger pore sizes and porosity.”
- Also stated in: § 3.1 Electrospun PDO Properties · plain
“Increasing the polymer concentration led to a linear increase in the fiber sizes, pore sizes and porosity but decreased the surface area to volume ratio.”
Quote in the paperSubstantial claim- Also stated in: § 3.1 Electrospun PDO Properties · plain
May combine two claims.
Findingown dataThe air-flow impedance method produced a statistically significant increase in scaffold pore size and porosity but did not affect fiber size or the surface area to volume ratio.
“The air-flow impedance method created a statistically significant increase in the pore size and porosity of the scaffold but did not impact the fiber size and the surface area to volume ratio.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningMacrophage conditioned media, especially from the 140 mg/ml scaffold, produced greater average sprout length and higher percentage sprout density than the 20 ng/ml VEGF positive control.
“BMMΦ conditioned media (especially in the case of 140 mg/ml scaffold) produced greater average length of sprouts and higher percentage density of sprouts compared to the positive control.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown databFGF production was statistically higher on the 140 mg/ml scaffold than the 60 mg/ml scaffold on Day 1 for M0s and M1s and on Day 3 for M2s.
“The production of bFGF was statistically higher on the 140 mg/ml scaffold compared to the 60 mg/ml scaffold on Day 1 in the case of M0s and M1s and on Day 3 in the case of M2s.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTNF-α levels fell by Day 3 and trended lower on the 140 mg/ml scaffold.
“TNF-α levels decreased on Day 3 and trended lower on the 140 mg/ml scaffold.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataM0 macrophages induced about 200-fold higher and M2 macrophages about 2-fold higher sprout length from the 140 mg/ml compared to the 60 mg/ml PDO scaffolds.
“Overall it was observed that M0s induced a ~200 fold higher and M2s induced a ~2 fold higher length of sprout from the 140 mg/ml compared to the 60 mg/ml PDO scaffolds.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCompared with the 60 mg/ml scaffolds, the 140 mg/ml scaffolds induced a 94-fold higher sprout density from M0s, 7-fold from M1s and 17-fold from M2s.
“Compared to the 60 mg/ml scaffolds, the 140 mg/ml scaffolds induced a 94 fold higher density of sprouts from M0s, 7 fold higher density of sprouts from M1s and 17 fold higher density of sprouts from M2s.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTGF-β1 production was statistically higher on the 140 mg/ml scaffold than the 60 mg/ml scaffold on Day 1 for M0s and on both Day 1 and Day 3 for M1s and M2s.
“The production of TGF-β1 was statistically higher on the 140 mg/ml scaffold compared to the 60 mg/ml scaffold on Day 1 in the case of M0s and on both Day 1 and 3 in the case of M1s and M2s.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIL-6 levels were not downregulated by the large fiber/pore size PDO and were unaffected by fiber/pore size on either Day 1 or Day 3.
“Similar to TNF-α, the levels of IL-6 were not downregulated by the large fiber/pore size PDO.”
- Also stated in: § 3.5 BMMΦ Mediator Secretion · plain
“IL-6 levels were unaffected by different fiber/pore sizes on either Day 1 or 3.”
Quote in the paperNot a substantial claim- Also stated in: § 3.5 BMMΦ Mediator Secretion · plain
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenEach experiment was done in triplicates and was reproduced at least twice.
“Each experiment was done in triplicates and was reproduced at least twice.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataThe data are instructive for rational design of implantable prosthetics to promote in situ regeneration.
“These data are instructive for the rationale design of implantable prosthetics designed to promote in situ regeneration.”
Quote in the paperNot a substantial claim- Rests on an assumption: In vitro BMMΦ responses to PDO scaffolds predict in vivo regeneration.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMΦ phenotype is a continuum of functional states between M1 and M2.
“The actual MΦ phenotype is viewed as a continuum of functional states between these two opposing ends [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Kou, 2011, Macrophage and dendritic cell phenotypic diversity in the context of biomaterials, J Biomed Mater Res A source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationM1s invade tissues by degrading and destroying them to clear pathogens and debris.
“It is known that M1s invade tissues by degrading and destroying it in an attempt to clear the tissue of pathogens and debris [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Kou, 2011, Macrophage and dendritic cell phenotypic diversity in the context of biomaterials, J Biomed Mater Res A source
Not checked in the free run.
May combine two claims.
Study design and conductown dataPDO scaffolds used in the study were endotoxin-free, with endotoxin levels 0.03-0.09 EU/ml, at least 12,000 times lower than the LPS concentration used to activate BMMΦs and below the USP standard of <0.25 EU/ml.
“The values for endotoxin content ranged from 0.03 – 0.09 EU/ml. Therefore, the highest endotoxin level for any scaffold was at least 12,000 times lower than the lowest amount used to activate BMMΦs (100 ng/ml of LPS corresponding to 1100 EU/ml) and well below the acceptable U.S. Pharmacopeia standard for clinical applications (<0.25 EU/ml). This study indicated that the PDO materials used in this”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] General chapter <85> bacterial endotoxins test, US pharmacopeia 31-national formulary 26. United States Pharmacopeial Convention, Rockville, MD; 2009.
Not checked in the free run.
May combine two claims.
PremisecitationPDO exhibits high flexibility, higher strength retention, slower absorption rate, and lower inflammatory response compared to poly(glycolide lactide) and poly(glycolic acid).
“It exhibits high flexibility, higher strength retention, slower absorption rate, and lower inflammatory response as compared to poly(glycolide lactide) and poly(glycolic acid) [18].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Boland, 2005, Electrospinning polydioxanone for biomedical applications, Acta Biomater source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe surface area to volume ratio formulas given by Boland et al. were used.
“The surface area to volume ratio of the scaffolds was calculated using the formulas given by Boland et al. [18]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Boland, 2005, Electrospinning polydioxanone for biomedical applications, Acta Biomater source
Not checked in the free run.
May combine two claims.
Interpretationown dataIncreased fiber/pore size shifts the macrophage phenotype in vitro towards a more M2, tissue regenerative phenotype, as evidenced by increased Arg1, TGF-β1, VEGF and bFGF expression.
“we have demonstrated that increased fiber/pore size shifts the MΦ phenotype to a more M2, tissue regenerative phenotype in vitro, as evidenced by increased Arg1, TGF-β1, VEGF, bFGF expression.”
- Also stated in: § 5. Conclusion · boosted
“BMMΦ acquire a more tissue regenerative M2 phenotype on scaffolds with larger fiber and pore dimensions as evidenced by the increased production of Arg1, VEGF, bFGF and TGF-β1.”
Quote in the paperSubstantial claim- Rests on an assumption: An M2 macrophage phenotype promotes healing and integration of the biomaterial with the host tissue, enhancing tissue regeneration.
- Also stated in: § 5. Conclusion · boosted
May combine two claims.
Interpretationown dataMyD88 has a role in regulating macrophage signaling on large versus small fiber/pore size PDO scaffolds, and scaffolds of different fiber/pore sizes signal to macrophages differently.
“This result indicates a potential role for MyD88 in regulating M1 BMMΦ signaling on the large vs. small fiber/pore size PDO scaffold.”
- Also stated in: § 4. Discussion · hedged
“The study indicates a potential role for MyD88 in regulating M1 BMMΦ signaling on the large vs. small fiber/pore size PDO scaffold.”
- Also stated in: § 5. Conclusion · boosted
“We have also shown that the scaffolds with different fiber/pore sizes signal to the BMMΦs differently and have identified MyD88 to be a key component involved in the signaling mechanism.”
Quote in the paperSubstantial claim- Also stated in: § 4. Discussion · hedged
May combine two claims.
PremisecitationBoth fiber and pore dimensions increase linearly with polymer concentration.
“Both fiber and pore dimensions increase linearly with concentration [18].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Boland, 2005, Electrospinning polydioxanone for biomedical applications, Acta Biomater source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationPore size is a crucial property of tissue engineering scaffolds and a key determinant of a scaffold's success through its influence on cell infiltration, nutrient/oxygen exchange and angiogenesis.
“Pore size has always been a crucial property of tissue engineering scaffolds and a key determinant of a scaffold’s success through their influence on cell infiltration, nutrient/oxygen exchange, and angiogenesis [41, 42].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [41] Yannas, 1989, Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [42] Dagalakis, 1980, Design of an artificial skin. Part III. Control of pore structure, J Biomed Mater Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataThese data are instructive for designing and engineering biomaterials that can promote in situ angiogenesis and tissue regeneration.
“These data are instructive for the design and engineering of biomaterials that can promote in situ angiogenesis and tissue regeneration.”
Quote in the paperNot a substantial claim- Rests on an assumption: An M2 macrophage phenotype promotes healing and integration of the biomaterial with the host tissue, enhancing tissue regeneration.
- Rests on an assumption: In vitro macrophage responses to scaffold architecture predict in vivo tissue regeneration outcomes.
May combine two claims.
Interpretationown dataMacrophages of M2 phenotype are functional and can support angiogenesis.
“we have shown that the BMMΦs of M2 phenotype are functional and can support angiogenesis.”
- Also stated in: § 5. Conclusion · boosted
“We further demonstrated that these BMMΦs of M2 phenotype are functional and support angiogenesis”
Quote in the paperSubstantial claim- Also stated in: § 5. Conclusion · boosted
May combine two claims.
Interpretationown dataThe 140 mg/ml PDO scaffold signals to M1 macrophages through a MyD88-dependent mechanism, whereas the 60 mg/ml PDO scaffold signals through a MyD88-independent mechanism.
“The 140 mg/ml PDO scaffold signal to M1s through a MyD88-dependant mechanism whereas, 60 mg/ml PDO scaffold signals through a MyD88-independent mechanism.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationMacrophages play a key role in the success and potential failure of any biomaterial.
“macrophages play a key role in the success and potential failure of any biomaterial”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Greisler et al. [21, 33–36]
Not checked in the free run.
- cites Valentin et al. [37] Valentin, 2009, Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds, Tissue Eng Part A source
Not checked in the free run.
- cites Brown et al. [4] Brown, 2009, Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component, Biomaterials source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationM1s are pro-inflammatory and microbicidal; M2s are immunomodulatory, reparative, and poorly microbicidal.
“In general, M1s or classically activated MΦs are pro-inflammatory and microbicidal, whereas M2s or alternatively activated MΦs are immunomodulatory, reparative, and poorly microbicidal [7–12].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [7] Fairweather, 2009, Alternatively activated macrophages in infection and autoimmunity, J Autoimmun source
Not checked in the free run.
- cites [8] Gordon, 2003, Alternative activation of macrophages, Nat Rev Immunol source
Not checked in the free run.
- cites [9] Gordon, 2010, Alternative activation of macrophages: mechanism and functions, Immunity source
Not checked in the free run.
- cites [10] Martinez, 2009, Alternative activation of macrophages: an immunologic functional perspective, Annu Rev Immunol source
Not checked in the free run.
- cites [11] Varin, 2009, Alternative activation of macrophages: immune function and cellular biology, Immunobiology source
Not checked in the free run.
- cites [12] Galli, 2011, Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils, Nat Immunol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe grid method has been used in a previous study to quantify migration of sprouts in a 3D matrix.
“This grid has been used in a previous study to quantify the migration of sprouts in a 3D matrix [29].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Vernon, 1999, A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices, Microvasc Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe results of this study can be extrapolated to predict macrophage responses to other biomaterials.
“The authors believe that the results of this study can be extrapolated to predict MΦ responses to other biomaterials as well.”
Quote in the paperNot a substantial claim- Rests on an assumption: An M2 macrophage phenotype promotes healing and integration of the biomaterial with the host tissue, enhancing tissue regeneration.
- Rests on an assumption: In vitro macrophage responses to scaffold architecture predict in vivo tissue regeneration outcomes.
Classified as probably not a substantial claim.
PremisecitationThe pore size, porosity and surface area to volume ratio were measured using a method described by Soliman et al.
“The pore size, porosity and surface area to volume ratio of the scaffolds was measured using a method described by Soliman et al. [26].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Soliman, 2011, Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density, J Biomed Mater Res A source
Not checked in the free run.
The paper relies on this without support.
In vitro BMMΦ responses to PDO scaffolds predict in vivo regeneration.
“These data are instructive for the rationale design of implantable prosthetics designed to promote in situ regeneration.”
The paper relies on this without support.
The differences in BMMΦ response across PDO scaffolds are due to fiber/pore size rather than other scaffold properties.
“BMMΦ cultured on these scaffolds showed a correlation between increasing fiber/pore size and increased expression of the M2 marker Arginase 1 (Arg1), along with decreased expression of the M1 marker inducible nitric oxide synthase (iNOS).”
The paper relies on this without support.
An M2 macrophage phenotype promotes healing and integration of the biomaterial with the host tissue, enhancing tissue regeneration.
“Such a functional M2 phenotype is likely to promote healing and integration of the biomaterial with the host tissue to enhance tissue regeneration.”
The paper relies on this without support.
In vitro macrophage responses to scaffold architecture predict in vivo tissue regeneration outcomes.
“These data are instructive for the design and engineering of biomaterials that can promote in situ angiogenesis and tissue regeneration.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The collection of secreted cytokines creates an anti-proliferative environment, destroys local matrix, and induces tissue reorganization, allowing increased migratory process and improved pathogen clearance.
“The collection of secreted cytokines creates an anti‐proliferative environment, destroys local matrix, and induces tissue reorganization, which allows for an increased migratory process and improved pathogen clearance.[ 36 ]”
From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [36]
The Introduction describes M1 macrophages as secreting pro-inflammatory cytokines, having anti-proliferative functions, and promoting matrix destruction and tissue reorganization that lets them migrate through injured tissue to clear pathogens. It attributes matrix destruction and reorganization to enzymes such as matrix metalloproteinases, however, not to the collection of secreted cytokines as the claim states. (LLM, conf=0.86)
Experimental — accuracy not yet measuredIncreased fiber/pore size (0.35 ± 0.2 to 2.8 ± 0.5 μm fiber diameter; 0.96 ± 0.09 to 14.73 ± 0.63 μm pore size) increased expression of M2 marker Arg1 and angiogenic cytokines, VEGF, TGF-β1, and bFGF, while decreasing the M1 marker iNOS.
“Increased fiber/pore size (0.35 ± 0.2 to 2.8 ± 0.5 µm fiber diameter; 0.96 ± 0.09 to 14.73 ± 0.63 µm pore size) increased expression of M2 marker Arg1 and angiogenic cytokines, VEGF, TGF‐β1, and basic fibroblast growth factor (bFGF), while decreasing the M1 marker iNOS.”
From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [36]
Results §§3.4–3.5 report higher Arg1, lower iNOS, and increased secretion of the named growth factors on larger fiber/pore scaffolds. The claim omits important limits: VEGF increased with size in M0 macrophages, but not M1 or M2, and bFGF increases depended on phenotype and day. The exact fiber and pore measurements are not stated in the passages available from our copy (Results §3.1 describes the size trend without those values); page numbers were not provided. (LLM, conf=0.87)
Experimental — accuracy not yet measuredLarger fiber diameter of polydioxanone enhanced M2 macrophage polarization.
“Garg et al. supported M2 polarization results when using mouse bone marrow‐derived macrophages (BMDMs), showing that larger fiber diameter of polydioxanone‐enhanced M2 macrophage polarization.[ 36 ]”
From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [36]
The Discussion reports that mouse bone marrow-derived macrophages became more M2-like on polydioxanone scaffolds with larger fibers and pores. But the Discussion and Results §3.8 say pore size was a more crucial regulator than fiber diameter; the study does not establish that larger fiber diameter alone enhanced M2 polarization. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPredictable angiogenesis can be identified by upregulation and secretion of VEGF by macrophages as seen in the FBR in vitro models.
“Hence, predictable angiogenesis can be identified by upregulation and secretion of VEGF by macrophages as seen in the FBR in vitro models.[ 36 , 41 ]”
From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [36]
Results §3.5 reports increased VEGF production by macrophages on larger-pore scaffolds for the M0 phenotype, and §3.6 reports greater endothelial sprouting with macrophage-conditioned media in an in vitro assay. The paper does not establish VEGF upregulation or secretion as a predictor of angiogenesis in FBR models; §3.6 also attributes sprouting to other growth factors in the conditioned media. (LLM, conf=0.86)
Experimental — accuracy not yet measuredMacrophages exposed to foreign biomaterials take part in fibrous encapsulation, remodeling, and angiogenesis.
“Macrophages that are exposed to foreign biomaterials take part in various processes, including fibrous encapsulation, remodeling, and angiogenesis.[ 36 ]”
From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [36]
VEGF, TGF-β, and bFGF were also upregulated, indicating that a larger pore size may also promote angiogenesis.
“Furthermore, VEGF, TGF‐β, and bFGF were also upregulated, indicating that a larger pore size may also promote angiogenesis.[ 36 ]”
From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [36]
Cells seeded on scaffolds with a higher fiber diameter and pore size showed a clear switch toward an M2 phenotype through the expression of the M2 marker Arginase 1, while displaying decreased levels of iNOS.
“Cells seeded on scaffolds with a higher fiber diameter and pore size showed a clear switch toward an M2 phenotype through the expression of the M2 marker Arginase 1, while displaying decreased levels of iNOS.”
From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [36]
Compared with microfibers, nanofibers cause less macrophage adhesion and inflammatory activation and reduce the host response.
“nanofibers elicit significantly less macrophage adhesion and inflammatory activation, and minimize the host response, when compared to microfibers.14-16”
From Micro- and Nanopatterned Topographical Cues for Regulating Macrophage Cell Shape and Phenotype (2015) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
M0 sprout-length fold change has a zero baseline
MinorThe paper reports no sprouting for M0-conditioned media from the 60 mg/ml scaffold. A sprout length at 140 mg/ml therefore cannot be described as 200-fold the length at 60 mg/ml.
“Overall it was observed that M0s induced a ~200 fold higher and M2s induced a ~2 fold higher length of sprout from the 140 mg/ml compared to the 60 mg/ml PDO scaffolds.”
“No sprouting was observed from the conditioned media of M0s cultured on the 60 mg/ml scaffold.”
M0 sprout-density fold change has a zero baseline
MinorWith no sprouting reported for M0-conditioned media from the 60 mg/ml scaffold, its density of sprouts is zero. The reported 94-fold density comparison against that scaffold is consequently undefined.
“Compared to the 60 mg/ml scaffolds, the 140 mg/ml scaffolds induced a 94 fold higher density of sprouts from M0s, 7 fold higher density of sprouts from M1s and 17 fold higher density of sprouts from M2s.”
“No sprouting was observed from the conditioned media of M0s cultured on the 60 mg/ml scaffold.”
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · see citing works
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · see citing works
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · see citing works
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138 · cited 2× · see citing works
“Upon exposure to implanted biomaterials, macrophages (MFs) fuse intomultinucleated giant cells called foreign-body giant cells (FBGCs), leading to fibrous encapsulation [1,2].”
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197 · see citing works
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840 · see citing works
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · see citing works
Biomaterials: Where We Have Been and Where We Are Going
Ratner, B. D., & Bryant, S. J. (2004) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.6.040803.140027 · Cited by 1,507 · see citing works
Biological Responses to Materials
Anderson, J. M. (2001) · Annual Review of Materials Research · doi:10.1146/annurev.matsci.31.1.81 · Cited by 1,465 · see citing works
Galli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055 · see citing works
Yannas, I. V., Lee, E., Orgill, D. P., Skrabut, E. M., & Murphy, G. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.933 · Cited by 972 · see citing works
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
Lyons, R. M., Keski‐Oja, J., & Moses, H. L. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.5.1659 · Cited by 969 · see citing works
Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., & Suttles, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.342 · Cited by 968 · see citing works
Brown, B. N., Ratner, B. D., Goodman, S. B., Amar, S., & Badylak, S. F. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.034 · Cited by 926 · cited 1× · see citing works
“The phenotypic profile of MΦs as M1 or M2 following exposure to the biomaterial can dictate remodeling and angiogenesis [3, 4].”
Brown, B. N., Valentin, J. E., Stewart-Akers, A. M., McCabe, G. P., & Badylak, S. F. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.040 · Cited by 896 · cited 3× · see citing works
“The phenotypic profile of MΦs as M1 or M2 following exposure to the biomaterial can dictate remodeling and angiogenesis [3, 4].”
Proangiogenic scaffolds as functional templates for cardiac tissue engineering
Madden, L. R., Mortisen, D. J., Sussman, E. M., Dupras, S. K., Fugate, J. A., Cuy, J. L., Hauch, K. D., Laflamme, M. A., Murry, C. E., & Ratner, B. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006442107 · Cited by 662 · see citing works
Alternative activation of macrophages: immune function and cellular biology
Varin, A., & Gordon, S. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.009 · Cited by 361 · see citing works
Design of an artificial skin. Part III. Control of pore structure
Dagalakis, N., Flink, J., Stasikelis, P., Burke, J. F., & Yannas, I. V. (1980) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820140417 · Cited by 358 · see citing works
Macrophage Participation in the Degradation and Remodeling of Extracellular Matrix Scaffolds
Valentin, J. E., Stewart-Akers, A. M., Gilbert, T. W., & Badylak, S. F. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0419 · Cited by 356 · see citing works
Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density
Soliman, S., Sant, S., Nichol, J. W., Khabiry, M., Traversa, E., & Khademhosseini, A. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33010 · Cited by 305 · see citing works
Electrospinning polydioxanone for biomedical applications
Boland, E. D., Coleman, B. D., Barnes, C. P., Simpson, D. G., Wnek, G. E., & Bowlin, G. L. (2005) · Acta Biomaterialia · doi:10.1016/j.actbio.2004.09.003 · Cited by 302 · see citing works
Self-citationAlternatively activated macrophages in infection and autoimmunity
Fairweather, D., & Cihakova, D. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.012 · Cited by 290 · see citing works
Saino, E., Focarete, M. L., Gualandi, C., Emanuele, E., Cornaglia, A. I., Imbriani, M., & Visai, L. (2011) · Biomacromolecules · doi:10.1021/bm200248h · Cited by 285 · see citing works
Gene expression profiling of cutaneous wound healing
Deonarine, K., Panelli, M. C., Stashower, M. E., Jin, P., Smith, K., Slade, H. B., Norwood, C., Wang, E., Marincola, F. M., & Stroncek, D. F. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-11 · Cited by 229 · see citing works
Electrospun polydioxanone–elastin blends: potential for bioresorbable vascular grafts
Sell, S. A., McClure, M. J., Barnes, C. P., Knapp, D. C., Walpoth, B. H., Simpson, D. G., & Bowlin, G. L. (2006) · Biomedical Materials · doi:10.1088/1748-6041/1/2/004 · Cited by 216 · see citing works
Self-citationSmall-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model
Roh, J. D., Nelson, G. N., Brennan, M. P., Mirensky, T. L., Yi, T., Hazlett, T. F., Tellides, G., Sinusas, A. J., Pober, J. S., Saltzman, W. M., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.041 · Cited by 192 · see citing works
Macrophage and dendritic cell phenotypic diversity in the context of biomaterials
Kou, P. M., & Babensee, J. E. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32971 · Cited by 190 · see citing works
Vernon, R. B., & Sage, E. H. (1999) · Microvascular Research · doi:10.1006/mvre.1998.2122 · Cited by 185 · see citing works
Chamberlain, L. M., Godek, M. L., Gonzalez‐Juarrero, M., & Grainger, D. W. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31930 · Cited by 112 · see citing works
McClure, M. J., Sell, S. A., Ayres, C. E., Simpson, D. G., & Bowlin, G. L. (2009) · Biomedical Materials · doi:10.1088/1748-6041/4/5/055010 · Cited by 112 · see citing works
Self-citationChen, Z., Htay, A., dos Santos, W. G., Gillies, G. T., Fillmore, H. L., Sholley, M. M., & Broaddus, W. C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9742-y · Cited by 108 · see citing works
Arterial Regeneration Over Polydioxanone Prostheses in the Rabbit
Greisler, H. P. (1987) · Archives of Surgery · doi:10.1001/archsurg.1987.01400180097019 · Cited by 80 · see citing works
Shokouhi, B., Coban, C., Hasirci, V., Aydin, E., Dhanasingh, A., Shi, N., Koyama, S., Akira, S., Zenke, M., & Sechi, A. S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.015 · Cited by 77 · see citing works
The use of air-flow impedance to control fiber deposition patterns during electrospinning
McClure, M. J., Wolfe, P. S., Simpson, D. G., Sell, S. A., & Bowlin, G. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.011 · Cited by 71 · see citing works
Self-citationPolyglactin 910/polydioxanone bicomponent totally resorbable vascular prostheses
Greisler, H. P., Endean, E. D., Klosak, J. J., Ellinger, J., Dennis, J. W., BUTTLE, K. F., & Kim, D. U. (1988) · Journal of Vascular Surgery · doi:10.1016/0741-5214(88)90016-x · Cited by 68 · see citing works
Macrophage/biomaterial interactions: The stimulation of endothelialization
Greisler, H. P., Dennis, J. W., Endean, E. D., Ellinger, J., Friesel, R. E., & Burgess, W. H. (1989) · Journal of Vascular Surgery · doi:10.1016/0741-5214(89)90478-3 · Cited by 62 · see citing works
Angiogenic potential of human macrophages on electrospun bioresorbable vascular grafts
Garg, K., Sell, S. A., Madurantakam, P., & Bowlin, G. L. (2009) · Biomedical Materials · doi:10.1088/1748-6041/4/3/031001 · Cited by 48 · see citing works
Self-citationPartially bioresorbable vascular grafts in dogs.
Greisler, H. P., Tattersall, C. W., Klosak, J. J., Ea, C., Garfield, J. D., & Kim, D. U. (1991) · PubMed · Cited by 41 · see citing works
Derivation of neointima in vascular grafts
Gewertz, B. L. (1989) · Journal of Vascular Surgery · doi:10.1016/0741-5214(89)90172-9 · Cited by 32 · see citing works
Garg, K., Ryan, J. J., & Bowlin, G. L. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33073 · Cited by 27 · see citing works
Self-citationMacrophage-biomaterial interactions with bioresorbable vascular prostheses.
Greisler, H. P. (1989) · PubMed · Cited by 23 · see citing works
Derivation of neointima in vascular grafts.
Greisler, H. P., Dennis, J. W., Endean, E. D., Ellinger, J., BUTTLE, K. F., & Kim, D. U. (1988) · PubMed · Cited by 20 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- General chapter <85> bacterial endotoxins test, US pharmacopeia 31-national formulary 26. United States Pharmacopeial Convention, Rockville, MD; 2009.
Cited by
Sorted by citations
Modulation of macrophage phenotype by cell shape
McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T., & Liu, W. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308887110 · Cited by 1,482 · see citing works
Osteoimmunomodulation for the development of advanced bone biomaterials
Chen, Z.-T., Klein, T. J., Murray, R., Crawford, R., Chang, J., Wu, C.-T., & Xiao, Y. (2016) · Materials Today · doi:10.1016/j.mattod.2015.11.004 · Cited by 558 · see citing works
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706 · see citing works
Current Advances in Immunomodulatory Biomaterials for Bone Regeneration
Lee, J., Byun, H., Perikamana, S. K. M., Lee, S., & Shin, H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801106 · Cited by 457 · see citing works
Material stiffness influences the polarization state, function and migration mode of macrophages
Sridharan, R., Cavanagh, B., Cameron, A. R., Kelly, D. J., & O'Brien, F. J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.048 · Cited by 450 · see citing works
Wang, Z., Cui, Y., Wang, J., Yang, X., Wu, Y., Wang, K., Gao, X., Li, D., Li, Y., Zheng, X., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.078 · Cited by 436 · see citing works
Physical and mechanical regulation of macrophage phenotype and function
McWhorter, F. Y., Davis, C. T., & Liu, W. F. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1796-8 · Cited by 437 · see citing works
Zhu, Y., Liang, H., Liu, X., Wu, J., Cao, Y., Wong, T. M., Kwan, K. Y.-H., Cheung, K., Wu, S., & Yeung, K. (2021) · Science Advances · doi:10.1126/sciadv.abf6654 · Cited by 415 · see citing works
Tailoring Materials for Modulation of Macrophage Fate
Li, J., Jiang, X., Li, H., Gelinsky, M., & Gu, Z. (2021) · Advanced Materials · doi:10.1002/adma.202004172 · Cited by 402 · see citing works
Zhang, K., Feng, Q., Fang, Z., Gu, L., & Bian, L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00071 · Cited by 397 · see citing works
Design Challenges in Polymeric Scaffolds for Tissue Engineering
Echeverria Molina, M. I., Malollari, K. G., & Komvopoulos, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.617141 · Cited by 397 · see citing works
Electrospinning: An enabling nanotechnology platform for drug delivery and regenerative medicine
Chen, S., Li, R., Li, X., & Xie, J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.05.001 · Cited by 383 · see citing works
Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design
Ogle, M. E., Segar, C. E., Sridhar, S., & Botchwey, E. A. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216650293 · Cited by 378 · see citing works
Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374 · see citing works
Micro- and Nanopatterned Topographical Cues for Regulating Macrophage Cell Shape and Phenotype
Luu, T. U., Gott, S. C., Woo, B. W. K., Rao, M. P., & Liu, W. F. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b10589 · Cited by 344 · see citing works
Immunomodulatory Biomaterials for Tissue Repair
Whitaker, R. C., Hernaez‐Estrada, B., Hernández, R. M., Santos‐Vizcaíno, E., & Spiller, K. L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00895 · Cited by 345 · see citing works
Zhang, D., Chen, Q., Shi, C., Chen, M., Ma, K., Wan, J., & Liu, R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202007226 · Cited by 304 · see citing works
Macrophage reaction against biomaterials in the mouse model–phenotypes, functions and markers
Klopfleisch, R. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.003 · Cited by 298 · see citing works
Functional Biomaterials for Bone Regeneration: A Lesson in Complex Biology
Armiento, A. R., Hatt, L. P., Rosenberg, G. S., Thompson, K., & Stoddart, M. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909874 · Cited by 275 · see citing works
Kluin, J., Talacua, H., Smits, A. I. P. M., Emmert, M. Y., Brugmans, M. C. P., Fioretta, E. S., Dijkman, P. E., Söntjens, S. H. M., Duijvelshoff, R., Dekker, S., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.007 · Cited by 270 · see citing works
Hernandez, J. L., & Woodrow, K. A. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102087 · Cited by 270 · see citing works
Enhancing cell infiltration of electrospun fibrous scaffolds in tissue regeneration
Wu, J., & Hong, Y. (2016) · Bioactive Materials · doi:10.1016/j.bioactmat.2016.07.001 · Cited by 262 · see citing works
Delgado, L. M., Bayon, Y., Pandit, A., & Zeugolis, D. I. (2015) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0290 · Cited by 272 · see citing works
Combating Implant Infections: Shifting Focus from Bacteria to Host
Yavari, S. A., Castenmiller, S. M., van Strijp, J. A. G., & Croes, M. (2020) · Advanced Materials · doi:10.1002/adma.202002962 · Cited by 257 · see citing works
Álvarez, M. M., Liu, J. C., Santiago, G. T., Cha, B.-H., Vishwakarma, A., Ghaemmaghami, A. M., & Khademhosseini, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.026 · Cited by 257 · see citing works
Biomaterial-driven in situ cardiovascular tissue engineering—a multi-disciplinary perspective
Wissing, T. B., Bonito, V., Bouten, C. V. C., & Smits, A. I. P. M. (2017) · npj Regenerative Medicine · doi:10.1038/s41536-017-0023-2 · Cited by 236 · see citing works
Xi, K., Gu, Y., Tang, J., Chen, H., Xu, Y., Wu, L., Cai, F., Deng, L., Yang, H., Shi, Q., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18265-3 · Cited by 231 · see citing works
Biomechanics and mechanobiology in functional tissue engineering
Guilak, F., Butler, D. L., Goldstein, S. A., & Baaijens, F. F. (2014) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2014.04.019 · Cited by 230 · see citing works
Niu, Y., Wang, Z., Shi, Y., Dong, L., & Wang, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.08.012 · Cited by 213 · see citing works
Kennedy, K. M., Bhaw‐Luximon, A., & Jhurry, D. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.12.034 · Cited by 214 · see citing works
Xie, Y., Hu, C., Feng, Y., Li, D., Ai, T., Huang, Y., Chen, X., Huang, L., & Tan, J. (2020) · Regenerative Biomaterials · doi:10.1093/rb/rbaa006 · Cited by 212 · see citing works
Bone Repair Biomaterials: A Perspective from Immunomodulation
Wang, Y., Zhang, H., Hu, Y., Jing, Y., Geng, Z., & Su, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202208639 · Cited by 209 · see citing works
Diverse functional roles of lipocalin-2 in the central nervous system
Jha, M. K., Lee, S., Park, D. H., Kook, H., Park, K.-G., Lee, I.-K., & Suk, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.006 · Cited by 195 · see citing works
Andorko, J. I., & Jewell, C. M. (2017) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10063 · Cited by 203 · see citing works
Przekora, A. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.01.061 · Cited by 202 · see citing works
Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases
Dort, J., Fabre, P., Molina, T., & Dumont, N. A. (2019) · Stem Cells International · doi:10.1155/2019/4761427 · Cited by 196 · see citing works
Strain-dependent modulation of macrophage polarization within scaffolds
Ballotta, V., Driessen-Mol, A., Bouten, C. V. C., & Baaijens, F. P. T. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.002 · Cited by 182 · see citing works
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery
Finbloom, J. A., Sousa, F., Stevens, M. M., & Desai, T. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.007 · Cited by 192 · see citing works
Rethinking Regenerative Medicine: A Macrophage-Centered Approach
Brown, B., Sicari, B. M., & Badylak, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00510 · Cited by 185 · see citing works
Abdelaziz, A. G., Nageh, H., Abdo, S. M., Abdalla, M. S., Amer, A. A., Abdal‐hay, A., & Barhoum, A. (2023) · Bioengineering · doi:10.3390/bioengineering10020204 · Cited by 202 · see citing works
Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction
Noskovicova, N., Hinz, B., & Pakshir, P. (2021) · Cells · doi:10.3390/cells10071794 · Cited by 184 · see citing works
Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli
Kong, L., Smith, W. W., & Hao, D. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14277 · Cited by 180 · see citing works
Zhang, B., Su, Y., Zhou, J., Zheng, Y., & Zhu, D. (2021) · Advanced Science · doi:10.1002/advs.202100446 · Cited by 176 · see citing works
Immunopolarization-regulated 3D printed-electrospun fibrous scaffolds for bone regeneration
Liu, X., Chen, M., Luo, J., Zhao, H., Zhou, X., Gu, Q., Yang, H., Zhu, X., Cui, W., & Shi, Q. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121037 · Cited by 173 · see citing works
Differential gene expression in human, murine, and cell line-derived macrophages upon polarization
Spiller, K. L., Wrona, E. A., Romero‐Torres, S., Pallotta, I., Graney, P. L., Witherel, C. E., Panicker, L. M., Feldman, R. A., Urbanska, A. M., Santambrogio, L., et al. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.017 · Cited by 172 · see citing works
Cai, Y., Chen, K., Liu, C., & Qu, X. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.04.019 · Cited by 169 · see citing works
Zhu, D., Johnson, T. K., Wang, Y., Thomas, M., Huynh, K., Yang, Q., Bond, V. C., Chen, Y. E., & Liu, D. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01669-9 · Cited by 143 · see citing works
Chen, S., Wang, H., Su, Y., John, J. V., McCarthy, A. D., Wong, S. L., & Xie, J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.035 · Cited by 141 · see citing works
Collagen Membrane and Immune Response in Guided Bone Regeneration: Recent Progress and Perspectives
Chu, C.-Y., Deng, J., Sun, X.-C., Qu, Y.-L., & Man, Y. (2017) · Tissue engineering. Part B, Reviews · doi:10.1089/ten.teb.2016.0463 · Cited by 129 · see citing works
Harnessing macrophage plasticity for tissue regeneration
Smith, T. D., Nagalla, R. R., Chen, E. Y., & Liu, W. F. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.012 · Cited by 138 · see citing works
Wang, J., Meng, F., Song, W., Jin, J., Ma, Q., Fei, D., Fang, L., Chen, L., Wang, Q., & Zhang, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s163956 · Cited by 137 · see citing works
Therapeutically relevant aspects in bone repair and regeneration
Pérez, R. A., Seo, S.-J., Won, J., Lee, E., Jang, J.-H., Knowles, J. C., & Kim, H. (2015) · Materials Today · doi:10.1016/j.mattod.2015.06.011 · Cited by 135 · see citing works
Innate Immunity and Biomaterials at the Nexus: Friends or Foes
Christo, S. N., Diener, K. R., Bachhuka, A., Vasilev, K. A., & Hayball, J. D. (2015) · BioMed Research International · doi:10.1155/2015/342304 · Cited by 133 · see citing works
Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
Pannell, M., Łabuz, D., Celik, M. Ö., Keye, J., Batra, A., Siegmund, B., & Machelska, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0735-z · Cited by 135 · see citing works
Biophysical regulation of macrophages in health and disease
Meli, V. S., Veerasubramanian, P. K., Atcha, H., Reitz, Z., Downing, T. L., & Liu, W. F. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-126r · Cited by 133 · see citing works
Hao, S., Meng, J., Zhang, Y., Liu, J., Nie, X., Wu, F., Yang, Y., Wang, C., Gu, N., & Xu, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.013 · Cited by 133 · see citing works
Zeng, X., Chen, B., Wang, L., Sun, Y., Jin, Z. H., Liu, X., Ouyang, L., & Liao, Y. J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.04.032 · Cited by 132 · see citing works
Matsuzaki, Y., John, K., Shoji, T., & Shinoka, T. (2019) · Applied Sciences · doi:10.3390/app9071274 · Cited by 131 · see citing works
Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications
Nazarnezhad, S., Baino, F., Kim, H., Webster, T. J., & Kargozar, S. (2020) · Nanomaterials · doi:10.3390/nano10081609 · Cited by 129 · see citing works
Spontaneous reversal of stenosis in tissue-engineered vascular grafts
Drews, J. D., Pepper, V. K., Best, C. A., Szafron, J. M., Cheatham, J. P., Yates, A. R., Hor, K. N., Zbinden, J. C., Chang, Y.-C., Mirhaidari, G. J. M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax6919 · Cited by 128 · see citing works
Won, J., Lee, Y. S., Park, J.-H., Lee, J., Shin, Y. S., Kim, C., Knowles, J. C., & Kim, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119548 · Cited by 125 · see citing works
Scaffold strategies for modulating immune microenvironment during bone regeneration
He, J., Chen, G., Liu, M., Xu, Z., Chen, H., Yang, L., & Lv, Y. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110411 · Cited by 127 · see citing works
Macrophage-Driven Biomaterial Degradation Depends on Scaffold Microarchitecture
Wissing, T. B., Bonito, V., van Haaften, E. E., van Doeselaar, M., Brugmans, M. C. P., Janssen, H. M., Bouten, C. V. C., & Smits, A. I. P. M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00087 · Cited by 124 · see citing works
Advanced Strategies for Modulation of the Material–Macrophage Interface
Huyer, L. D., Pascual‐Gil, S., Wang, Y., Mandla, S., Yee, B., & Radisic, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909331 · Cited by 123 · see citing works
Progress in biomaterials inspired by the extracellular matrix
Chen, Z., Du, C., Liu, S., Liu, J., Yang, Y., Dong, L., Zhao, W., Huang, W., & Lei, Y. (2024) · Giant · doi:10.1016/j.giant.2024.100323 · Cited by 122 · see citing works
Wang, X., Maxwell, K. G., Wang, K., Bowers, D. T., Flanders, J. A., Liu, W., Wang, L.-H., Liu, Q., Liu, C., Naji, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb4601 · Cited by 119 · see citing works
Study on the influence of scaffold morphology and structure on osteogenic performance
Zhou, J., Xiong, S., Liu, M., Yang, H., Wei, P., Yi, F., Ouyang, M., Xi, H., Long, Z., Liu, Y., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1127162 · Cited by 119 · see citing works
Bone regeneration in implant dentistry: Which are the factors affecting the clinical outcome?
Donos, N., Akcalı, A., Padhye, N. M., Sculean, A., & Calciolari, E. (2023) · Periodontology 2000 · doi:10.1111/prd.12518 · Cited by 119 · see citing works
Garg, K., Ward, C. L., Rathbone, C. R., & Corona, B. T. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-2006-6 · Cited by 117 · see citing works
Self-citationLiu, Y., Liu, X., Hua, W., Wei, Q., Fang, X., Zhao, Z., Ge, C., Liu, C., Chen, C., Tao, Y., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.049 · Cited by 116 · see citing works
The Role of Innate and Adaptive Immune Cells in Skeletal Muscle Regeneration
Ziemkiewicz, N., Hilliard, G. M., Pullen, N., & Garg, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063265 · Cited by 112 · see citing works
Self-citationMechanical biocompatibility of highly deformable biomedical materials
Mazza, E., & Ehret, A. E. (2015) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2015.03.023 · Cited by 110 · see citing works
The Effect of Biomaterials Used for Tissue Regeneration Purposes on Polarization of Macrophages
Boersema, G. S. A., Grotenhuis, N., Bayon, Y., Lange, J. F., & Bastiaansen-Jenniskens, Y. M. (2016) · BioResearch open access · doi:10.1089/biores.2015.0041 · Cited by 110 · see citing works
Biomaterials strategies to balance inflammation and tenogenesis for tendon repair
Hou, J., Yang, R., Vuong, I., Li, F., Kong, J., & Mao, H. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.043 · Cited by 110 · see citing works
A review of preparation methods of porous skin tissue engineering scaffolds
Zhang, Z., Feng, Y., Wang, L., Liu, D., Qin, C., & Shi, Y. (2022) · Materials Today Communications · doi:10.1016/j.mtcomm.2022.104109 · Cited by 110 · see citing works
In vitro response of macrophage polarization to a keratin biomaterial
Fearing, B. V., & Dyke, M. E. V. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.04.003 · Cited by 109 · see citing works
Mechano-Immunomodulation: Mechanoresponsive Changes in Macrophage Activity and Polarization
Adams, S., Wuescher, L. M., Worth, R., & Yildirim-Ayan, E. (2019) · Annals of Biomedical Engineering · doi:10.1007/s10439-019-02302-4 · Cited by 96 · see citing works
Engineered Sulfated Polysaccharides for Biomedical Applications
Arlov, Ø., Rütsche, D., Asadikorayem, M., Öztürk, E., & Zenobi‐Wong, M. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010732 · Cited by 100 · see citing works
Ambre, A. H., Katti, D. R., & Katti, K. S. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35342 · Cited by 98 · see citing works
Zhang, D., Yao, Y., Duan, Y.-Y., Yu, X., Shi, H.-F., Nakkala, J. R., Zuo, X., Hong, L., Mao, Z.-W., & Gao, C.-Y. (2020) · ACS Applied Materials and Interfaces · doi:10.1021/acsami.9b20321 · Cited by 89 · see citing works
Zhang, L., Dong, Y., Zhang, N., Shi, J., Zhang, X., Qi, C., Midgley, A. C., & Wang, S. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110618 · Cited by 95 · see citing works
Ye, J., Xie, C., Wang, C., Huang, J., Yin, Z., Heng, B. C., Chen, X., & Shen, W. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.017 · Cited by 97 · see citing works
Adhikari, U., An, X., Rijal, N. P., Hopkins, T., Khanal, S., Chavez, T., Tatu, R. R., Sankar, J., Little, K. J., Hom, D. B., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.04.061 · Cited by 91 · see citing works
Biomaterials-Mediated Regulation of Macrophage Cell Fate
Liu, Y., & Segura, T. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.609297 · Cited by 92 · see citing works
Multifunctional Scaffolds and Synergistic Strategies in Tissue Engineering and Regenerative Medicine
Muzzio, N., Moya, S. E., & Romero, G. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060792 · Cited by 92 · see citing works
Li, W., Dai, F., Zhang, S., Xu, F., Xu, Z., Liao, S., Zeng, L., Li, S., & Ai, F. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c02001 · Cited by 92 · see citing works
Collagen Cross-Linking: Biophysical, Biochemical, and Biological Response Analysis
Delgado, L. M., Fuller, K. P., & Zeugolis, D. (2017) · Tissue Engineering. Part A · doi:10.1089/ten.tea.2016.0415 · Cited by 84 · see citing works
Impact of surface chemistry and topography on the function of antigen presenting cells
Rostam, H. M., Singh, S., Vrana, N. E., Alexander, M. R., & Ghaemmaghami, A. M. (2015) · Biomaterials Science · doi:10.1039/c4bm00375f · Cited by 88 · see citing works
Bessa‐Gonçalves, M., Ribeiro-Machado, C., Costa, M. M., Ribeiro, C. N. M., Barbosa, J., Barbosa, M. A., & Santos, S. G. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.10.046 · Cited by 87 · see citing works
In Vivo Chemical Sensors: Role of Biocompatibility on Performance and Utility
Soto, R. J., Hall, J. R., Brown, M. D., Taylor, J. B., & Schoenfisch, M. H. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04251 · Cited by 85 · see citing works
Yang, Y., Lei, D., Zou, H., Huang, S., Yang, Q., Li, S., Qing, F., Ye, X., You, Z., & Zhao, Q. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.037 · Cited by 85 · see citing works
Applications of electrospun scaffolds with enlarged pores in tissue engineering
Zhang, Y., Zhang, M., Cheng, D., Xu, S., Du, C., Xie, L., & Zhao, W. (2022) · Biomaterials Science · doi:10.1039/d1bm01651b · Cited by 81 · see citing works
Khosravi, R., Best, C. A., Allen, R. A., Stowell, C. E. T., Onwuka, E. A., Zhuang, J. J., Lee, Y.-U., Yi, T., Bersi, M. R., Shinoka, T., et al. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1545-7 · Cited by 80 · see citing works
Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation
Ferrini, A., Stevens, M. M., Sattler, S., & Rosenthal, N. A. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00026 · Cited by 79 · see citing works
Zhang, Q., Hwang, J. W., Oh, J.-H., Park, C. H., Chung, S. H., Lee, Y., Baek, J., Ryoo, H., & Woo, K. M. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.007 · Cited by 76 · see citing works
Host Response to Biomaterials for Cartilage Tissue Engineering: Key to Remodeling
Fu, W. E., Liu, S., Chen, M., Tian, G., Zha, K., Yang, Z., Jiang, S., Li, M., Sui, X., Chen, Z., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.664592 · Cited by 79 · see citing works
Topographical modulation of macrophage phenotype by shrink-film multi-scale wrinkles
Wang, T., Luu, T. U., Chen, A., Khine, M., & Liu, W. F. (2016) · Biomaterials Science · doi:10.1039/c6bm00224b · Cited by 77 · see citing works
Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implants
Hernandez, J. L., Park, J., Yao, S., Blakney, A. K., Nguyen, H. V., Katz, B. H., Jensen, J. T., & Woodrow, K. A. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120806 · Cited by 78 · see citing works
The Role of In Vitro Immune Response Assessment for Biomaterials
Lock, A. M., Cornish, J., & Musson, D. S. (2019) · Journal of Functional Biomaterials · doi:10.3390/jfb10030031 · Cited by 77 · see citing works
Triple-Layer Vascular Grafts Fabricated by Combined E-Jet 3D Printing and Electrospinning
Huang, R., Gao, X., Wang, J., Chen, H., Tong, C., Tan, Y., & Tan, Z. (2018) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-2065-z · Cited by 76 · see citing works
- Authors
- Garg, K., Pullen, N. A., Oskeritzian, C. A., Ryan, J. J., & Bowlin, G. L.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Bowlin, Gary L.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 34
- Issue
- 18
- Pages
- 4439-4451
- ISSN
- 0142-9612 (ISSN-L)
- PMC
- PMC3623371
- OpenAlex
- W2070438219
- Cited by
- 457
- References
- 43
- Citations by year
- 2026: 28 · 2025: 35 · 2024: 40 · 2023: 35 · 2022: 48 · 2021: 65 · 2020: 55 · 2019: 39 · 2018: 24 · 2017: 26 · 2016: 32 · 2015: 12 · 2014: 17 · 2013: 1
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (K12GM093857)
- National Institute of Allergy and Infectious Diseases (R01AI059638, R01AI095494)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- macrophage polarization, M1/M2 macrophages, electrospun scaffolds, fiber diameter, pore size, polydioxanone, bone marrow-derived macrophages, arginase-1, inducible nitric oxide synthase, angiogenic cytokines, vascular endothelial growth factor, TGF-β1, basic fibroblast growth factor, MyD88, scaffold porosity, tissue regeneration
- MeSH terms
- Animals, Arginase, Bone Marrow Cells, Endotoxins, Macrophages, Mice, Inbred C57BL, Microscopy, Electron, Scanning, Phenotype, Signal Transduction, Porosity, Polydioxanone, Cell Polarity, Culture Media, Conditioned, Neovascularization, Physiologic, Tissue Engineering, Endothelial Cells, Mice, Nitric Oxide Synthase Type II, Myeloid Differentiation Factor 88, Tissue Scaffolds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review